459 related articles for article (PubMed ID: 30967651)
21. Two Faces of Vitamin C-Antioxidative and Pro-Oxidative Agent.
Kaźmierczak-Barańska J; Boguszewska K; Adamus-Grabicka A; Karwowski BT
Nutrients; 2020 May; 12(5):. PubMed ID: 32455696
[TBL] [Abstract][Full Text] [Related]
22. Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly.
Shenoy N; Creagan E; Witzig T; Levine M
Cancer Cell; 2018 Nov; 34(5):700-706. PubMed ID: 30174242
[TBL] [Abstract][Full Text] [Related]
23. Vitamin C versus Cancer: Ascorbic Acid Radical and Impairment of Mitochondrial Respiration?
Bakalova R; Zhelev Z; Miller T; Aoki I; Higashi T
Oxid Med Cell Longev; 2020; 2020():1504048. PubMed ID: 32411317
[TBL] [Abstract][Full Text] [Related]
24. Targeting Epigenetics in Cancer.
Bennett RL; Licht JD
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
[TBL] [Abstract][Full Text] [Related]
25. Targeting components of epigenome by small molecules.
You JS; Han JH
Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764
[TBL] [Abstract][Full Text] [Related]
26. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.
Heaney ML; Gardner JR; Karasavvas N; Golde DW; Scheinberg DA; Smith EA; O'Connor OA
Cancer Res; 2008 Oct; 68(19):8031-8. PubMed ID: 18829561
[TBL] [Abstract][Full Text] [Related]
27. Vitamin C at high concentrations induces cytotoxicity in malignant melanoma but promotes tumor growth at low concentrations.
Yang G; Yan Y; Ma Y; Yang Y
Mol Carcinog; 2017 Aug; 56(8):1965-1976. PubMed ID: 28370562
[TBL] [Abstract][Full Text] [Related]
28. Metabolic control by dehydroascorbic acid: Questions and controversies in cancer cells.
Ferrada L; Salazar K; Nualart F
J Cell Physiol; 2019 Nov; 234(11):19331-19338. PubMed ID: 30963581
[TBL] [Abstract][Full Text] [Related]
29. Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation.
Leekha A; Gurjar BS; Tyagi A; Rizvi MA; Verma AK
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2503-2514. PubMed ID: 27613187
[TBL] [Abstract][Full Text] [Related]
30. High-dose vitamin C enhances cancer immunotherapy.
Magrì A; Germano G; Lorenzato A; Lamba S; Chilà R; Montone M; Amodio V; Ceruti T; Sassi F; Arena S; Abrignani S; D'Incalci M; Zucchetti M; Di Nicolantonio F; Bardelli A
Sci Transl Med; 2020 Feb; 12(532):. PubMed ID: 32102933
[TBL] [Abstract][Full Text] [Related]
31. Review of high-dose intravenous vitamin C as an anticancer agent.
Wilson MK; Baguley BC; Wall C; Jameson MB; Findlay MP
Asia Pac J Clin Oncol; 2014 Mar; 10(1):22-37. PubMed ID: 24571058
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic perspectives on cancer chemotherapy response.
Liu MZ; McLeod HL; He FZ; Chen XP; Zhou HH; Shu Y; Zhang W
Pharmacogenomics; 2014 Apr; 15(5):699-715. PubMed ID: 24798726
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
34. Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.
Kirkpatrick DL; Powis G
Antioxid Redox Signal; 2017 Feb; 26(6):262-273. PubMed ID: 26983373
[TBL] [Abstract][Full Text] [Related]
35. New potential biomarker for stratification of patients for pharmacological vitamin C in adjuvant settings of cancer therapy.
Bakalova R; Zhelev Z; Miller T; Aoki I; Higashi T
Redox Biol; 2020 Jan; 28():101357. PubMed ID: 31678721
[TBL] [Abstract][Full Text] [Related]
36. Retinol palmitate and ascorbic acid: Role in oncological prevention and therapy.
de Carvalho Melo-Cavalcante AA; da Rocha Sousa L; Alencar MVOB; de Oliveira Santos JV; da Mata AMO; Paz MFCJ; de Carvalho RM; Nunes NMF; Islam MT; Mendes AN; Gonçalves JCR; da Silva FCC; Ferreira PMP; de Castro E Sousaa JM
Biomed Pharmacother; 2019 Jan; 109():1394-1405. PubMed ID: 30551390
[TBL] [Abstract][Full Text] [Related]
37. Promising strategies: Combination of epigenetic inhibitors for cancer therapy.
Gronemeyer H
Int J Cancer; 2020 Nov; 147(10):2656-2657. PubMed ID: 32599650
[No Abstract] [Full Text] [Related]
38. What if cell culture media do not mimic in vivo redox settings?
Spasojević I
Redox Rep; 2016 May; 21(3):127-9. PubMed ID: 26221760
[TBL] [Abstract][Full Text] [Related]
39. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
40. Orthomolecular oncology review: ascorbic acid and cancer 25 years later.
González MJ; Miranda-Massari JR; Mora EM; Guzmán A; Riordan NH; Riordan HD; Casciari JJ; Jackson JA; Román-Franco A
Integr Cancer Ther; 2005 Mar; 4(1):32-44. PubMed ID: 15695476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
